Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Brea...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SCHAFFHAUSEN, Switzerland, Dec 18, 2020 /PRNewswire-AsiaNet/ -- Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Arterial Hy...
Authors: LATEST ASIANET NEWS RELEASES